This press release replaces the release issued today at 9:15am EDT.

Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. 

Revealia™: A Breakthrough in Cancer Detection through Advanced AI and Machine Learning

Ainos Plans To Conduct the Study at National Taiwan University Hospital, a Premier Taiwanese Medical Center for HIV Management

The U.S. FDA Have Granted Orphan Drug Designation (ODD) for the Company's VELDONA^® Low-Dose Oral Interferon Formulation as a Potential Treatment for Oral Warts in HIV-Positive Patients